Sanofi-Aventis partly to recall "Clexane inj."

Sanofi-Aventis announced to recall about 30 batches of Enoxaparin (Clexane inj.) in 58 countries over the world including Korea, Africa, Asia, Latin America and Europe at a level of keeping its safety according to the intensive survey especially on the over contents of the active ingredient.

Sanofi said that the over contents of active ingredient supposedly occurred in the filling process t...